GlucoTrack (GCTK) Competitors $0.20 -0.03 (-11.75%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.19 -0.01 (-5.37%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK vs. BTCY, SSKN, IINN, NURO, WOK, PAVM, STRR, BSGM, MHUA, and LUCYShould you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include Biotricity (BTCY), STRATA Skin Sciences (SSKN), Inspira Technologies Oxy B.H.N. (IINN), NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), PAVmed (PAVM), Star Equity (STRR), BioSig Technologies (BSGM), Meihua International Medical Technologies (MHUA), and Innovative Eyewear (LUCY). These companies are all part of the "medical equipment" industry. GlucoTrack vs. Biotricity STRATA Skin Sciences Inspira Technologies Oxy B.H.N. NeuroMetrix WORK Medical Technology Group LTD Ordinary Shares PAVmed Star Equity BioSig Technologies Meihua International Medical Technologies Innovative Eyewear GlucoTrack (NASDAQ:GCTK) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings. Does the MarketBeat Community prefer GCTK or BTCY? GlucoTrack and Biotricity both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGlucoTrackN/AN/ABiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Is GCTK or BTCY more profitable? GlucoTrack has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat GlucoTrack's return on equity.Company Net Margins Return on Equity Return on Assets GlucoTrackN/A -826.43% -707.26% Biotricity -80.42%N/A -188.47% Do analysts prefer GCTK or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GlucoTrack 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders have more ownership in GCTK or BTCY? 10.9% of GlucoTrack shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 46.5% of GlucoTrack shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer GCTK or BTCY? In the previous week, GlucoTrack had 2 more articles in the media than Biotricity. MarketBeat recorded 2 mentions for GlucoTrack and 0 mentions for Biotricity. GlucoTrack's average media sentiment score of 1.43 beat Biotricity's score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media. Company Overall Sentiment GlucoTrack Positive Biotricity Neutral Which has more volatility & risk, GCTK or BTCY? GlucoTrack has a beta of -0.29, meaning that its share price is 129% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Which has higher earnings and valuation, GCTK or BTCY? GlucoTrack has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlucoTrackN/AN/A-$7.10M-$56.600.00Biotricity$12.06M0.86-$14.09M-$1.08-0.39 SummaryGlucoTrack beats Biotricity on 7 of the 13 factors compared between the two stocks. Remove Ads Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCTK vs. The Competition Export to ExcelMetricGlucoTrackSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.14M$4.35B$5.63B$7.84BDividend YieldN/A48.03%5.33%4.01%P/E Ratio0.0028.4223.5518.73Price / SalesN/A49.26388.1990.75Price / CashN/A51.0838.1734.64Price / Book0.016.116.894.23Net Income-$7.10M$67.64M$3.20B$247.47M7 Day Performance-31.32%-5.25%-3.06%-2.29%1 Month Performance-43.24%-4.12%1.51%-5.81%1 Year Performance-99.38%10.65%9.37%-0.96% GlucoTrack Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCTKGlucoTrack1.8842 of 5 stars$0.21-11.8%N/A-99.4%$2.14MN/A0.005Short Interest ↓Gap DownBTCYBiotricityN/A$0.44-7.7%N/A-71.8%$10.90M$12.06M-0.4140SSKNSTRATA Skin Sciences2.8811 of 5 stars$2.57-4.1%$6.00+133.5%-28.8%$10.72M$32.68M-0.97120Earnings ReportShort Interest ↑News CoverageGap DownIINNInspira Technologies Oxy B.H.N.0.8066 of 5 stars$0.77-0.6%N/A-60.8%$9.72MN/A0.0020Gap DownNURONeuroMetrix0.8726 of 5 stars$4.55+0.8%N/A+4.2%$9.33M$3.77M-0.9920Analyst ForecastShort Interest ↓News CoverageWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.62-3.1%N/AN/A$9.05M$11.51M0.00226Gap DownPAVMPAVmed4.4474 of 5 stars$0.80-1.2%$19.00+2,275.0%-65.0%$8.86M$4.03M-0.1890Short Interest ↓News CoverageSTRRStar Equity1.1784 of 5 stars$2.67+10.3%N/A-43.2%$8.59M$50.38M-1.04460Analyst RevisionHigh Trading VolumeBSGMBioSig Technologies1.8156 of 5 stars$0.49-9.4%$2.75+456.9%-10.7%$8.51M$39,000.000.0050News CoverageHigh Trading VolumeMHUAMeihua International Medical Technologies2.0869 of 5 stars$0.34-1.0%N/A-53.9%$8.49M$94.25M0.00620Short Interest ↓LUCYInnovative Eyewear0.9043 of 5 stars$3.18-5.6%$20.00+528.9%-49.8%$7.77M$1.56M-0.339Earnings ReportGap Down Remove Ads Related Companies and Tools Related Companies BTCY Alternatives SSKN Alternatives IINN Alternatives NURO Alternatives WOK Alternatives PAVM Alternatives STRR Alternatives BSGM Alternatives MHUA Alternatives LUCY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GCTK) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GCTK Stock Free GCTK Stock Alerts